Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study
Josefina Lorena Razzini, Iago Giné-Vázquez, Jing Jin, María-Isolina Santiago-Pérez, Olaia Pérez-Martínez, María-Teresa Otero-Barrós, Nuria Suárez-Gaiche, R. Kramer, Leticia Platero-Alonso, Rosa-María Álvarez-Gil, Olga-María Ces-Ozores, Victoria Nartallo-Penas, Susana Mirás-Carballal, Marta Piñeiro-Sotelo, Juan-Manuel González-Pérez, Carmen Rodríguez-Tenreiro-Sánchez, Ángela Manzanares-Casteleiro, Ana Dacosta-Urbieta, Cintia Álvarez-Smith, Irene Rivero-Calle, Antonio Salas, Carmen Durán-Parrondo, Narmeen Mallah, Federico Martinón-Torres
Topics & Concepts
MedicineObservational studyPrimary carePediatricsRespiratory systemPalivizumabEmergency medicineVirusProspective cohort studyIntensive care medicineIncidence (geometry)MononegaviralesPneumovirinaeMEDLINEPneumovirusCohort studyRespiratory illnessEpidemiologyPneumoniaVirologyHospital admissionBronchiolitisHealth careRespiratory viral infections researchImmunodeficiency and Autoimmune DisordersPneumonia and Respiratory Infections